Status:
UNKNOWN
Study of ORL-1M (D-mannose) in Patients With CDG-Ib
Lead Sponsor:
Orpha Labs
Conditions:
CDG Ib
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE1
PHASE2
Brief Summary
Study of ORL-1M in Patients With CDG-Ib
Eligibility Criteria
Inclusion
- Diagnosis of CGD-1b.
- Less than 18 years old.
Exclusion
- Diagnosis of any other disease that is not a manifestation of CGD-1b.
Key Trial Info
Start Date :
March 31 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03404869
Start Date
March 31 2015
End Date
June 1 2019
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orpha Labs
Ankara, Turkey (Türkiye), 06100